Healthcare Industry Insights: October 2020

Friday 30 October 2020

Veterinary Services Market: Key Growth Drivers, Challenges, Leading Key Players Review

The global Veterinary Services Market size is expected to reach USD 142.04 billion by 2025, according to a new report by Grand View Research, Inc., experiencing a CAGR of 5.6% during the forecast period. Rising concerns regarding food security and safety are encouraging the adoption of veterinary services worldwide. In addition, increasing pet adoption is one of the primary growth stimulants for the market.

In addition, the advent of risk-based management systems, designed to analyze real-time fluctuations in food-borne and zoonotic disease prevalence, is widening the scope for growth of the veterinary services market. Veterinary services play a critical role in risk aversion and facilitate the implementation of various guidelines issued by regulatory authorities to maintain overall food safety. It also facilitates investigation of animal disease outbreaks and the implementation of remedial measures after the identification of an outbreak. The aforementioned factors are expected to help the market gain tremendous momentum over the coming years.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/veterinary-services-market

Further key findings from the report suggest:

Production animal accounted for the largest share in the market in 2017 owing to high adoption of facilities for livestock to maintain biosecurity
Cattle was the leading revenue contributor among production animals in 2017 owing to increasing penetration of services such as hoof care and artificial insemination
The companion animals segment is projected to expand at a lucrative rate during the forecast period owing to an unprecedented increase in their adoption for associated health benefits for humans such as greater psychological stability, lower blood pressure, and reduced anxiety attacks
North America dominated the global veterinary services market in 2017 as a result of the local presence of private veterinarians that directly supply these services to consumers
Asia Pacific is anticipated to register an exponential CAGR during the same period owing to strong clinical urgency to curb the high incidence of zoonotic diseases and management of sudden disease outbreaks such as Ebola and swine influenza
The market is highly fragmented in nature and the key participants adopt strategies such as regional expansion to gain competitive advantage. For instance, in June 2018, Mars Petcare acquired AniCura and Linnaeus to broaden its geographical presence in the U.K. and Sweden respectively.

About Grand View Research

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

MDS Drugs Market: Key Growth Drivers, Challenges, Leading Key Players Review

The global Myelodysplastic Syndrome (MDS) Drugs Market size is expected to reach USD 2.4 billion by 2022, according to a new report by Grand View Research, Inc., exhibiting a 9.7% CAGR during the forecast period. Factors such as strong product pipeline, rising geriatric population, and favorable government initiatives are driving the market.

MDS is caused by mutation of one or more genes that control development of blood cells. Patients with this condition may present with clinical manifestations such as thrombocytopenia, neutropenia, and anemia. Although majority of cases (over 90%) are reported in people over the age of 60, the condition can occur at any age, more frequently in men than in women. About 30% of MDS cases advance to acute myeloid leukemia (AML).

The immunomodulatory drug segment is expected to retain its dominant position in the MDS drugs market due to strong sales of Revlimid. Supported by potential approvals of luspatercept and Aranesp, the anti-anemics drug segment is forecast to gain higher market share than hypomethylating agents, thus contributing significantly to the overall expansion of the market.

Developing novel drugs for the treatment of rare subsets of MDS patients is a key challenge as the disease is highly heterogeneous at the molecular level. In addition, morbidity issues and poor quality of life due to incapacitating effects of the standard of care treatment paradigms are causes of inconvenience for geriatric population.

Request a free sample copy or view report summary: Myelodysplastic Syndrome Drugs Market Report

Myelodysplastic Syndrome Drugs Market Report Highlights

An estimated 60,000 people in U.S. are living with myelodysplastic syndrome, with approximately 10,000-15,000 new cases being reported annually
U.S. dominated the global MDS drugs market with more than 48.0% share in 2016 owing to rising disease incidence and launch of strong pipeline candidates
Emerging markets such as India, China, and South Korea are expected to exhibit lucrative growth during the forecast period due to favorable government policies, rising awareness about hematological malignancies, increased investment, and improved healthcare infrastructure
Immunomodulatory drugs led the drug classes with a market share of more than 54.0% in 2016. Hypomethylating agents are projected to witness a double-digit decline in market share due to expected patent expirations
Celgene, Amgen, Otsuka, and Takeda are some of the key players operating in this area; Celgene accounted for 95.2% of the market in 2016, driven by strong sales of Revlimid and Vidaza
Currently, there are about 45 pipeline drugs in various stages of clinical development. Promising pipeline candidates such as Aranesp, luspatercept, Vyxeos, guadecitabine, and pevonedistat are expected to generate significant revenue upon launch.

About Grand View Research

Endoscopes Market Size Worth $20.4 Billion By 2027 | CAGR: 8.8%

The global Endoscopes Market size is expected to reach USD 20.4 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 8.8% over the forecast period. The market is driven by factors such as increasing geriatric population; growing preference for minimally invasive surgeries; and rise in incidences of cancer, gastrointestinal diseases, and other chronic diseases. The introduction of new technologies in gastrointestinal endoscopy that offers improved visualization and diagnosis, along with high awareness about advanced endoscopes used to perform advanced procedures such as Endoscopic Retrograde Cholangiopancreatography (ERCP), upper gastrointestinal endoscopy, and sigmoidoscopy among medical professionals, also acts as a driving factor for the overall market growth.

Gastrointestinal (GI) endoscopy emerged as the leading application segment in the global market. Growing geriatric population and rising burden of gastrointestinal diseases are among the key factors responsible for rising demand for GI endoscopy. According to a recent study published by the World Health Organization (WHO), the percentage of the global population aged over 60 years is expected to double from about 12% to 22% between 2000 and 2050. In addition, disposable endoscopes are increasingly used owing to technological advancements and launch of new products and the risk of infection associated with conventional reusable endoscopes.

Moreover, endoscopic surgeries require small incisions to diagnose and treat various conditions and are gaining wide acceptance globally. Surgeons prefer robotic surgeries and endoscopic surgeries over conventional open surgeries. Minimally invasive surgeries result in reduced risk of post-operative complications, shorter hospital stay and recovery time, and decreased blood loss during surgeries. These minimally invasive surgeries are an economically viable alternative to open surgeries. Preference for these surgeries has led to an increase in development of capsule endoscopes and robot-assisted endoscopes.

Request a free sample copy or view report summary: Endoscopes Market Report

Endoscopes Market Report Highlights

Flexible endoscopes emerged as the largest product segment in 2019 with a share of over 50.0% in the global market owing to benefits such as increased safety and efficiency
Amongst applications,GI endoscopy accounted for the largest share in 2019; however, urology endoscopy is projected to register the highest CAGR over the forecast period
Hospitals emerged as the leading end-use segment in 2019 and is expected to register a significant growth rate over the forecast period owing to the high number of endoscopic surgeries performed in hospitals
North America dominated the global endoscopes market in 2019 due to rising geriatric population and increasing demand for minimally invasive surgeries in the region
Key players operating in the market include Fujifilm Holdings Corporation, Olympus Corporation LLC, Stryker Corporation, Ethicon Endo-Surgery, Richard Wolf GmbH, Karl Storz, and Boston Scientific Corporation

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Eye Examination Equipment Market Size Worth $8.8 Billion By 2025 | CAGR: 6.2%

The global Eye Examination Equipment Market size is expected to reach USD 8.8 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 6.2% during the forecast period. Increasing prevalence of eye-related disorders is anticipated to drive the demand for advanced ophthalmic treatment procedures over the forecast period.

Growing global geriatric population is another factor propelling the optometry/eye examination equipment market. According to U.S. Census Bureau published on June 2017, the total population aged 65 and older in the U.S. increased to 49.2 million in 2016, accounting for 15.2% of the total population, from 35 million in 2000, which represented only 12.0% of the total population. Mounting cases of age-related disorders including glaucoma, cataracts, and age-related macular degeneration (AMD) are likely to stoke the growth of the market.

Request a free sample copy or view report summary: Eye Examination Equipment Market Report

Eye Examination Equipment Market Report Highlights

Growing prevalence of eye diseases and influx of technologically advanced ophthalmic devices are anticipated to boost the growth of the optometry/eye examination equipment market over the forecast period
Ophthalmic ultrasound imaging systems are expected to exhibit the fastest growth over the coming years, owing to rising penetration of B-Scan ultrasound
Hospitals accounted for the largest revenue share in the market in 2017, owing to rising ophthalmic surgical procedures in hospitals
North America held the dominant share in the optometry/eye examination equipment market in 2017, due to presence of well-established healthcare setting and treatment facility, surging demand for technologically advanced healthcare products, and favorable reimbursement facilities.
The market in Asia Pacific, especially Japan and India, are estimated to witness remarkable growth during the forecast period due to increasing investments in the healthcare sector. In Feb 2017, the Japan government invested USD 500 million to build a new eye hospital in order to fulfil the vision 2020 approach by WHO.
Some of the key companies present in the market are Carl Zeiss Meditec AG; Bausch & Lomb Inc.; Johnson & Johnson Vision Care Inc.; Novartis AG; NIDEK CO.; LTD; and Canon

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Thursday 29 October 2020

Cranial Fixation and Stabilization Devices Market with Key players | Stryker, Medtronic, Ostomed, Johnson & Johnson, Integra LifeSciences Corporation

The global Cranial Fixation & Stabilization Devices Market size is expected to reach USD 2.6 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 5.6% during the forecast period. Increasing prevalence of neurological disorders and road accidents is expected to drive the demand for cranial surgeries and thereby, fixation & stabilization devices over the forecast period.

Growing demand for minimally invasive surgery due to their associated advantages is another factor propelling the industry. For instance, cranial fixation performed by using mini titanium plates & screws is simple, safe, and cost effective solution for immediate stability and repositioning than traditional sutures. In addition, increasing awareness among neurosurgeons is expected to fuel the adoption. There is a significant increase in the adoption of cranial fixation pins by neurosurgeons in patients with age below 5 years over the past few years.

Request a sample copy or view summary of this report@
https://www.grandviewresearch.com/industry-analysis/cranial-fixation-stabilization-devices-market

Further key findings from the report suggest:

Cranial fixation is the procedure in which bone fragments or grafts and bone flaps are fixed to cranium to offer stable closure in surgery.
Increase in demand for cranial fixation plates & screws due to rise in surgical procedures such as craniotomies, cranial trauma & fixation is anticipated to boost the demand for cranial fixation devices over the forecast period
Stabilization product segment is expected to witness significant growth in the coming years due to technological advancements in the field of neuroscience
The hospital segment accounted for the largest revenue share as the number of neurosurgical procedures performed in the hospitals are more
The adoption of cranial stabilization devices is expected to increase in ambulatory surgical centers as the demand for outpatient craniotomies is increasing rapidly
North America held the dominant market share in 2017, due to presence of well established healthcare industry, high awareness among end users, and demand for technologically advanced healthcare products
The Asia pacific regional market, especially China and India, are anticipated to witness remarkable growth over the forecast period as incidence of neurological conditions due to road accidents is high in these regions
The market is competitive in nature as companies are involved in building up strategies such as merger & acquisitions, geographic expansions, and new product developments to gain market share
Some of the key companies present in the market are Stryker, Medtronic, Ostomed, Johnson & Johnson, Integra LifeSciences Corporation, KLS Martin Group, and B. Braun Melsungen AG.

Pharmaceutical Sterility Testing Market Size Worth $2.0 Billion By 2025

The global Pharmaceutical Sterility Testing Market size is expected to reach USD 2.0 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a healthy CAGR of 11.8% over the forecast period. Increasing number of drug launches coupled with the rising R&D expenditure across the globe is expected to be the key market growth drivers.

Technological advancements in sterility testing methods led to reduction of the procedural time and human intervention, thereby increasing the efficiency and accuracy of these tests. Latest advancements are flexible to suit the safety requirements of innovative products. The FDA also relaxed its regulatory requirements to allow the use of modern sterility tests for ensuring product safety.

Outsourcing of sterility testing is a strategy adopted by many companies in order to reduce cost. Moreover, several contract laboratories are available, which provide quality sterility testing at economic prices. Outsourcing of sterility testing also reduces the need for personnel training, equipment purchases, and manufacturing facility changes.

Regulatory framework for sterile products in pharmacies is increasingly becoming stringent owing to the several adverse events, such as meningitis outbreak (2012), associated with unsafe sterile products compounded in pharmacies. Moreover, the Drug Quality and Security Act provides the FDA authority to monitor and regulate the compounding of drugs, thereby, increasing adoption of sterility testing procedures by the compounding pharmacies.

Developing countries are harmonizing the regulatory framework with ICH standards and are also undertaking initiatives to boost the domestic production by providing incentives and tax concessions. Thus, developing nations are considered to be the future area for expansion of operations and outsourcing of sterility testing by multinational companies.

Request a sample copy or view summary of this report@ https://www.grandviewresearch.com/industry-analysis/pharmaceutical-sterility-testing-market

Further key findings from the study suggest:

The outsourcing pharmaceutical sterility testing market is anticipated to register a CAGR of 12.0% over the forecast period
Among end-users, the others segment includes hospitals, biopharmaceuticals, clinics, and research labs and it is anticipated to witness the maximum CAGR over the forecast period
Bacterial endotoxin testing segment led the global pharmaceutical sterility testing market with a market share of over 39.0% in 2016
The North America region is anticipated to expand at CAGR of 11.7% during the estimated period
Developing countries, especially India and China, are expected to witness a remarkable growth over the coming years
Some of the key companies in this market are SGS SA; Toxikon, Inc.; Pace Analytical Services, LLC; Boston Analytical; Charles River Laboratories International, Inc.; and Nelson Laboratories LLC.

Wednesday 28 October 2020

Europe Nutrition and Supplements Market Trends, Analysis, Outlook and Future Scope

The Europe Nutrition And Supplements Market is expected to reach USD 52.9 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 5.9% during the forecast period. It is primarily driven by increasing awareness about healthy lifestyle, weight management, sports nutrition, healthy eating, and wellbeing.

Growing geriatric population and surging healthcare costs in the region are among the key trends estimated to trigger market growth. Increasing health consciousness among consumers and rising willingness to spend on nutrition and dietary supplements are also projected to augur well for the growth of the market. Moreover, upswing in the number of distribution channels for nutraceuticals is poised to improve their accessibility, which will stimulate the growth of the market.

Spiraling demand for nutraceuticals from consumers and growing emphasis on food content are also anticipated to escalate the growth of the market. In terms of age group, the adult segment dominated the market in 2016 owing to presence of a large target population in the region. However, the children segment is likely to witness the fastest growth with a CAGR of 7.5% over the forecast period owing to rising number of product launches for children & infants and expanding base of children suffering from malnutrition. According to European Commission, 51 million children under 5 years of age are affected by malnutrition and it is one of the main causes of 45.0% of deaths in this age group.

Additional supplements are further segmented into dietary supplements & functional foods. Dietary supplements are expected to register a higher CAGR during the forecast period. These include vitamins, minerals, enzymes, amino acids, and others. Enzyme-based dietary supplements are estimated to experience the fastest growth with a CAGR of 10.0% over the forecast period.

Request a free sample copy or view report summary: Europe Nutrition and Supplements Market Report

Europe Nutrition and Supplements Market Report Highlights

Italy was the leading revenue contributor in the region in 2016 due to soaring adoption of dietary supplements, rising awareness regarding their advantages, and increasing efforts by pharmacists to promote healthy lifestyle
The U.K. is the fastest growing market with a CAGR of 7.1% between 2017 and 2025
Sports nutrition is the fastest growing segment during the forecast period, which is anticipated to post a CAGR of 7.5%
Some of the prominent players operating in this market are Amway; Bayer AG; Sanofi; Abbott; Nestle; Pfizer, Inc.; General Nutrition Centers, Inc.; and LivaNova PLC

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Aortic Valve Replacement Devices Market: Industry Analysis and Outlook Report

The global Aortic Valve Replacement Market size is expected to reach USD 13.49 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 11.1% during the forecast period. Technological advancements in aortic valves and favorable reimbursement policies are boosting the growth of the market. Rising demand for minimally invasive surgeries is also triggering the growth of the market.

Widening base of geriatric population is one of the key growth stimulants. As per data published by Medicare and Medicaid services, the number of aortic stenosis patients over 65 years of age is constantly increasing in the U.S. Thus, rising incidence of aortic stenosis coupled with improving treatment rates is expected to bolster the growth of the market over the forecast period. In addition, growing preference for minimally invasive surgeries is escalating the growth of the market. These procedures cause lesser trauma to patient along with better outcomes and facilitate faster recovery than conventional open-heart surgeries. MIS requires relatively lesser number of hospital stays and is hence economically more viable than conventional invasive surgeries.

Favorable reimbursement policies are one of the crucial factors anticipated to drive the market in the near future. Centers for Medicare & Medicaid Services (CMS) announced that it would provide coverage for TAVR under the Medicare National Coverage Determination policy. Moreover, increasing number of clinical studies undertaken by key players for extending interventional scope, analyzing safety of devices, and assessing subsequent treatment alternatives is also working in favor of the market. However, product recalls due to safety concerns are projected to inhibit the growth of the market.

Request a free sample copy or view report summary: Aortic Valve Replacement Devices Market Report

Aortic Valve Replacement Devices Market Report Highlights

Minimally invasive surgeries emerged as the leading surgery type owing to various advantages associated with them, such as limited trauma, quicker recovery, and cost-effectiveness
The transcatheter valve segment accounted for the largest revenue share in 2017 due to rising number of clinical studies for expanding their applications
In terms of end users, hospitals were the dominant revenue contributor in 2017 and ambulatory surgery centers (ASCs) are expected to exhibit remarkable CAGR over the forecast period
North America emerged as the largest regional market with a revenue share of 41.9% in 2017 and Asia Pacific is anticipated to post the highest CAGR over the forecast period
The market is highly fragmented in nature. Some of the prominent companies operating in the market are Edwards Lifesciences Corporation, Boston Scientific Corporation, St. Jude Medical, CryoLife, Medtronic, and LivoNova.

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Pharmacokinetics Services Market: Key Growth Drivers, Challenges, Leading Key Players Review

The global Pharmacokinetics Services Market size is expected to reach USD 1.2 billion by 2025, according to a new report by Grand View Research, Inc., registering an 8.3% CAGR during the forecast period. Rising adoption of pharmacokinetic and toxicology studies for determination of several parameters such as no-observed-effect levels (NOEL), human equivalent doses (HED) levels, and pharmacokinetic/pharmacodynamic (PK/PD) drivers are expected to fuel market growth.

Thorough understanding of the pharmacokinetic profile of a potential drug candidate plays a major role in the success of a drug discovery program. In addition to this, regulatory bodies have played a major role in the progress of this market through establishing defined guidelines for conducting PK studies. There are a substantial number of CROs engaged in conducting PK studies in accordance with relevant EMEA, ICH, FDA, GCP, and other regulatory guidelines.

Growing concern for effective implementation of PK services in the drug development process is anticipated to drive investments in this sector. Several conferences and certification courses are being conducted across the world to increase the understanding of various paradigms associated with pharmacokinetics application in clinical and preclinical drug development.

Request a sample copy or view summary of this report@
https://www.grandviewresearch.com/industry-analysis/pharmacokinetics-services-market

Further key findings from the report suggest:

Based on drug type, PK services for small molecules dominated the market in 2017 and is expected to maintain its lead during the forecast period fueled by high service penetration and growing popularity of generics
PK services for large molecules are expected to grow significantly during the forecast period, driven by presence of significant number of biologics and biosimilars in the clinical development phase
Presence of a large number of biopharmaceutical and pharmaceutical manufacturing entities in U.S. has resulted in North America accounting for the largest share in 2017
Asia Pacific is expected to grow lucratively throughout the forecast period thanks to constant economic growth in several countries, which has attracted significant attention from global CROs and resulted in business expansions
Pharmaceutical Product Development, LLC; Charles River Laboratories International, Inc.; PAREXEL International Corporation; and Eurofins Scientific, Inc. are some of the key service providers
These CROs are undertaking various initiatives in order to capitalize on new market avenues and enhance their share in the future market.

About Us:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com